Vial Stock
HealthTechLooking to sell Vial stock or options?
Vial operates a clinical trial platform designed to decrease the expenses and obstacles associated with drug development. The platform collaborates with clinics, transforming them into research sites for clinical trials by implementing necessary equipment, locating trials, handling administrative tasks, conducting data entries, managing patient appointments and recruitment, invoicing, and ensuring compliance. This allows biotechnology companies to transition into different trial phases and enables partner clinics to boost their revenue.
Investors Include:
General Catalyst, TriplePoint Venture Growth BDC, Buckley Ventures, TriplePoint Capital, BoxGroup, Byers Capital.